- Report
- August 2025
- 192 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- September 2025
- 184 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- January 2025
- 429 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- August 2025
- 149 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- May 2025
- 120 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- August 2025
- 148 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- June 2025
- 200 Pages
Global
From €2196EUR$2,490USD£1,901GBP
- Report
- April 2025
- 400 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 187 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 187 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- September 2025
- 388 Pages
Global
From €5159EUR$5,850USD£4,466GBP

The Artificial Heart market is a subset of the Cardiovascular Devices market, which includes a variety of medical devices used to treat heart conditions. Artificial Hearts are mechanical devices that are implanted into a patient's body to replace a failing heart. These devices are typically used as a bridge to heart transplantation, providing a temporary solution for patients with end-stage heart failure. Artificial Hearts are designed to mimic the natural functions of the heart, such as pumping blood and regulating blood pressure.
The Artificial Heart market is highly competitive, with a number of companies offering a range of products. Companies in the market include Abiomed, SynCardia Systems, Carmat, and WorldHeart Corporation. These companies are focused on developing innovative Artificial Heart technologies to improve patient outcomes and reduce healthcare costs. Show Less Read more